The enemy of good
By setting narrow limits on study eligibility, we risk treatment rationing through regulatory restriction.
Mikkael Sekeres MD
“By setting narrow limits on eligibility, we court rationing through regulatory restriction.” Great editorial on downstream effects of narrow clinical trial eligibility on insurance reimbursement by
Matt Kalaycio, MD
There are many reasons to broaden eligibility criteria for clinical trials, including this one. The enemy of good